BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 10458216)

  • 21. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings].
    Kühnel G; Horn LC; Fischer U; Hesse S; Seese A; Georgi P; Kluge R
    Zentralbl Gynakol; 2001 Apr; 123(4):229-35. PubMed ID: 11370532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.
    Loft A; Berthelsen AK; Roed H; Ottosen C; Lundvall L; Knudsen J; Nedergaard L; Højgaard L; Engelholm SA
    Gynecol Oncol; 2007 Jul; 106(1):29-34. PubMed ID: 17482666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
    Martinez A; Voglimacci M; Lusque A; Ducassou A; Gladieff L; Dupuis N; Angeles MA; Martinez C; Tanguy Le Gac Y; Chantalat E; Hitzel A; Courbon F; Ferron G; Gabiache E
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1252-1260. PubMed ID: 31915897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy.
    Chou HH; Chang TC; Yen TC; Ng KK; Hsueh S; Ma SY; Chang CJ; Huang HJ; Chao A; Wu TI; Jung SM; Wu YC; Lin CT; Huang KG; Lai CH
    J Clin Oncol; 2006 Jan; 24(1):123-8. PubMed ID: 16382121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.
    Grigsby PW; Siegel BA; Dehdashti F
    J Clin Oncol; 2001 Sep; 19(17):3745-9. PubMed ID: 11533097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical use of laparoscopic ultrasonography in detecting nodal metastasis in advanced-stage cervical carcinoma.
    Cheung TH; Lo KW; Yim SF; Siu NS; Yu MM
    Int J Gynaecol Obstet; 2011 Feb; 112(2):154-8. PubMed ID: 21130450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
    Yilmaz M; Adli M; Celen Z; Zincirkeser S; Dirier A
    Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interest of para-aortic lymphadenectomy for locally advanced cervical cancer in the era of PET scanning.
    Khebbeb S; Rathat G; Serrand C; Bourdon A; Ferrer C; Duraes M
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():234-239. PubMed ID: 35397374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
    Graafland NM; Leijte JA; Valdés Olmos RA; Hoefnagel CA; Teertstra HJ; Horenblas S
    Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.
    Inubashiri E; Hata K; Kanenishi K; Shiota A; Ohno M; Yamamoto Y; Nishiyama Y; Ohkawa M; Hata T
    J Obstet Gynaecol Res; 2009 Feb; 35(1):26-34. PubMed ID: 19215544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.
    Sironi S; Buda A; Picchio M; Perego P; Moreni R; Pellegrino A; Colombo M; Mangioni C; Messa C; Fazio F
    Radiology; 2006 Jan; 238(1):272-9. PubMed ID: 16304090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
    Kim SK; Choi HJ; Park SY; Lee HY; Seo SS; Yoo CW; Jung DC; Kang S; Cho KS
    Eur J Cancer; 2009 Aug; 45(12):2103-9. PubMed ID: 19403303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
    Wahl RL; Siegel BA; Coleman RE; Gatsonis CG;
    J Clin Oncol; 2004 Jan; 22(2):277-85. PubMed ID: 14722036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan staging prior to planned radical hysterectomy and pelvic lymphadenectomy.
    Unger JB; Ivy JJ; Ramaswamy MR; Charrier A; Connor P
    Int J Gynecol Cancer; 2005; 15(6):1060-4. PubMed ID: 16343182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers].
    Bentivegna E; Uzan C; Gouy S; Leboulleux S; Duvillard P; Lumbroso J; Haie-Meder C; Morice P
    Gynecol Obstet Fertil; 2011 Apr; 39(4):193-7. PubMed ID: 21429783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
    Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
    Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Added value of para-aortic surgical staging compared to
    De Cuypere M; Lovinfosse P; Goffin F; Gennigens C; Rovira R; Duch J; Fastrez M; Gebhart G; Squifflet JL; Luyckx M; Charaf G; Crener K; Buxant F; Bucella D; Jouret M; Hustinx R; Kridelka F
    Eur J Surg Oncol; 2020 May; 46(5):883-887. PubMed ID: 31784203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancer.
    Klar M; Meyer PT; Hancke K; Brink I; Orlowska-Volk M; Gitsch G; Denschlag D
    Anticancer Res; 2010 Sep; 30(9):3787-90. PubMed ID: 20944170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.